Response to: Correspondence on ‘Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study’ by Yu et al
Response to: Correspondence on ‘Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study’ by Yu et al. // Annals of the Rheumatic Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0003496726004231?dgcid=rss_sd_all
Response to: Correspondence on ‘Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study’ by Yu et al. Annals of the Rheumatic Diseases. https://www.sciencedirect.com/science/article/pii/S0003496726004231?dgcid=rss_sd_all
“Response to: Correspondence on ‘Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study’ by Yu et al.” Annals of the Rheumatic Diseases.
@article{article97419,
title = {Response to: Correspondence on ‘Progression from symptom onset to rheumatoid arthritis: is the trajectory similar in anticitrullinated protein antibody-positive and -negative disease? A comparative longitudinal study’ by Yu et al},
journal = {Annals of the Rheumatic Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0003496726004231?dgcid=rss_sd_all}
}